ArticleJournal of controlled release : official journal of the Controlled Release Society2012

EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.

Michael A Sandoval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.